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ABSTRACT: This essay explores the deployment of hope within bio-
medicine. Drawing on Michel Foucault’s account of biopolitics, it 
argues that hope works in the service of biopolitical imperatives to 
govern life, and to secure, optimize, and speculate on that life. The 
essay broadly considers the operations of affect in biomedicine, and 
specifically examines the governing function of affective conventions 
of hope—that is, the perceptual, emotional, and corporeal modes of 
managing and responding to events that support biomedicine’s telos 
toward the affirmation of life. In relation to illness, hope conditions 
responses to bodily vulnerability and uncertainty, manages the pres-
ent for the future, and relentlessly affirms life. The essay grounds these 
claims in an investigation of cancer activism and treatment, wherein 
hope is a weapon to fight cancer, as the target of war. Documenting 
the ways that hope is increasingly militarized, commodified, rou-
tinized, and delimited in the neoliberal era, the essay explores how 
such conventions of hope are actively made and maintained through 
aspects of cancer-related biomedical encounters—in what it calls in-
frastructures of care and bioethics of faith within oncology. The essay 
concludes by considering alternative hope tactics—“hoping for other 
things”—in relation to cancer.
Do you know what hope is? It’s magic and it’s free.
It’s not in a prescription. It’s not in an IV.
It punctuates our laughter. It sparkles in our tears.
It simmers under sorrows. It dissipates our fears.
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Do you know what hope is? It’s reaching past today.
It’s dreaming of tomorrow. It’s trying a new way.
It’s questioning the answer. It’s always seeking more.
It’s rumors of a break. It’s whispers of a cure.
A roller coaster ride. Of remedies, unsure.
Do you know what hope is? It’s candy for the soul.
It’s perfume for the spirit. To share it makes you whole.
Keep Hope Forever Until We Find A CURE.
—“Banners of Hope”1
“The exercise of power is not a violence that sometimes hides, or an 
implicitly renewed consent. It operates on the field of possibilities 
in which the behavior of active subjects is able to inscribe itself. It 
is a set of actions on possible actions; it incites, it induces, it se-
duces. . . . The exercise of power is a ‘conduct of conducts’ and a 
management of possibilities.”
—Michel Foucault2 
Hope carries utopian promise; it offers possibilities of a “not yet,” 
a “to come,” and an imagining of life otherwise. In contemporary 
critique, hope has often been deployed as the means to effect radical 
social transformation and the reinvention of contemporary reality.3 
It is seen as a way of reaching beyond the stymied conditions of 
today by orienting toward the horizon of an alternative tomorrow. 
Hope is invoked as an incantation, under conditions of uncertainty; 
it is an insistent affirmation of the ability to effect change. This 
change can be imagined politically and economically, psychologi-
cally and corporeally. Indeed, hope is ubiquitous in contemporary 
culture, from US President Barack Obama’s political memoir—The 
Audacity of Hope—to international food drives—the “Convoy of 
Hope”4—to biomedical understandings of illness and health. As in 
the above quotation from “Banners of Hope” (an online outreach 
for children with life-threatening diseases), hope is the panacea 
for chronic or terminal illness. Hope might be seen to operate as a 
logic within the biomedical arena, one that structures subjectivities, 
1. See “Final Speech Inspiration’s ‘Banners of Hope’” on the Sunshine after the Rain 
blog at http://mbozadji.blogspot.com/.
2. Michel Foucault, Essential Works of Foucault, 1954–1984, vol. 3: Power, trans. Robert 
Hurley, ed. James D. Faubion (New York: The New Press, 2001), p. 341.
3. See, for example, Mary Zournazi, Hope: New Philosophies for Change (Annandale, 
NSW, Australia: Pluto Press, 2002). 
4. See the Convoy of Hope website at http://www.convoyofhope.org/.
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social realities, and corporeal states. It incites particular behaviors; 
it induces certain forms of community and belonging; it seduces us 
to believe in the possible transcendence of bodily limits and/or tem-
poral constraints. As we explore in this essay, hope is the guiding 
principle of biomedicine’s telos toward the affirmation of life. 
 This essay argues that hope is conventionalized in particular ways 
that work in the service of biopolitical imperatives to govern life, 
and to secure, optimize, and speculate on that life. We orient the 
investigation toward the regulation of affect within the US biomedi-
cal arena to consider how affective conventions—that is, the percep-
tual, emotional, and corporeal modes of managing and responding 
to events—of hope perform a governing function.5 In relation to ill-
ness, for example, they condition responses to bodily vulnerability 
and uncertainty, manage the present for the future, and relentlessly 
affirm life. We ground these broad claims in an examination of the 
dominant affective conventions of hope at work in cancer activism 
and treatment. Documenting the ways in which hope is increas-
ingly militarized,6 commodified, routinized, and delimited in the 
neoliberal era, the essay explores how such conventions of hope 
are actively made and maintained through aspects of cancer-related 
biomedical encounters—what we call infrastructures of care and bio-
ethics of faith within oncology. The essay concludes by considering 
alternative hope tactics—“hoping for other things”—in relation to 
cancer. 
Hope as Biomedical Affect: Biopolitical and  
Disciplinary Deployments
Within the “affective turn” of contemporary theory, affect is under-
stood in a range of ways: as immanent to the subject, the pre-discursive 
or biologized substrate; as that which escapes reason, rationality, 
and intention; as nonsignifying, formless intensity or vital energy 
in excess of the human and the social. For example, Eric Shouse, 
5. Thus, we focus here on the governing logics of hope, rather than on forms of 
resistance to such governing. Our interest is to explore how hope is deployed to compel 
individuals to think about themselves in particular ways, respond to biomedical facts 
and treatments in specific ways, and act according to dominant biomedical discourses. 
This is not to say that there are not myriad ways in which individuals and collectives 
challenge or reject such forms of governing.
6. Our use of the term militarized refers to the general process by which hope has been 
imbued with martial qualities and practiced across a range of scales for the purposes of 
security; namely, the organization of life—of institutions, knowledge, and social 
relations—according to the imperatives of national defense or individual survival, 
including everyday, banal neoliberal processes that naturalize social inequities and seek 
to contain social conflict by bounding spaces and bodies. 
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referring to Brian Massumi’s theory of affect, states that “[a]n affect is 
a nonconscious experience of intensity; it is a moment of unformed 
and unstructured potential.”7 Affect is understood to occur below 
the threshold of consciousness and cognition, independent of signi-
fication and meaning.8 It is also seen as “proceeding directly from the 
body—and indeed between bodies—without the interference or limi-
tations of consciousness, or representation: for this reason, its force 
is, strictly speaking, pre-personal.”9 Such a pre-personal possibility 
between bodies (or material intensities) is considered to be the space 
from which a dynamic politics can emerge: “an essentially dynamic, 
self-organizing biology/nature is presented as the guarantor for an 
emancipatory and creative politics.”10 
An alternative argument, as advanced by Clare Hemmings, is that 
“affect might in fact be valuable [to criticism] precisely to the extent 
that it is not autonomous.”11 This suggests that we can think about 
affect as actively constructed through representations, practices, and 
interpersonal relations; as socially and materially arranged; and, im-
portantly, as conditioned through sets of conventions. These con-
ventions organize our affections, sentiments, perceptions, and pro-
clivities; they call on us to generate and cultivate certain responses 
over others. As such, affect is inextricable from social realities and 
essential to subjectivity. In contradistinction to the emphasis on 
affect’s immanence in much contemporary scholarship, the point 
here is to examine the nonimmanent dynamics of affect, and the 
mechanisms through which affect is deployed within the biomedi-
cal and broader social realm. To do so, we employ a poststructuralist 
framework indebted to Michel Foucault that de-ontologizes emo-
tion and perception to consider the active processes and effects of 
thinking and feeling.
Multiple affects become solidified through practices and insti-
tutions. Importantly, different affects are valued and socially en-
dorsed more than others; some affects become sedimented and 
thus dominant, while others remain subjugated and contestatory. 
7. Eric Shouse, “Feeling, Emotion, Affect,” M/C Journal: A Journal of Media and Culture 
8:6 (2005). http://journal.media-culture.org.au/0512/03-shouse.php.
8. Ruth Leys, “The Turn to Affect: A Critique,” Critical Inquiry 37:3 (2011): 434–472, 
quote on p. 443. 
9. Constantina Papoulias and Felicity Callard, “Biology’s Gift: Interrogating the Turn to 
Affect,” Body and Society 16:1 (2010): 29–56, quote on p. 35 (emphasis in original).
10. Ibid., p. 49.
11. Clare Hemmings, “Invoking Affect,” Cultural Studies 19:5 (2005): 548–567, quote on 
p. 565 (emphasis added).
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Furthermore, certain understandings or affective responses are seen 
as more acceptable than others within the contours of a particular 
affect. Certain elements of a given affect mark the limits of knowl-
edge and experience of that affect. These complexities call for a nu-
anced approach to the analysis of affect, one that takes into account 
the manifold social implications of affective conventions and their 
material effects. Such an investigation is necessary because of the 
differential ways that affect forms and conditions bodies, subjectivi-
ties, and broader group identities and social relations. The stakes of 
conceptualizing affect as social rather than ontological are that poli-
tics remains embedded in the embodied subjects and critical prac-
tices of everyday life. 
 Affects are productive, in that they form and condition bodies/
selves. We are interested in considering how the affect of hope is de-
ployed in biomedicine, in ways that achieve particular ends or forms 
of life. Accordingly, the affect of hope can be said to have a governing 
function. We understand governing function in terms of Foucault’s 
theory of biopolitics, an account of a form of power that governs 
life—that has “taken control of life in general.”12 We are concerned 
with biopolitical mechanisms—specifically, how hope is deployed 
within the biomedical field—in ways that come to structure life and 
discipline subjects. For Foucault, discipline is that set of practices that 
endows the individual body with capacities and “‘makes’ individu-
als; it is the specific technique of a power that regards individuals 
as both objects and instruments of its exercise.”13 This body that is 
individualized, and the individual that is made, emerges through 
the exercise of norms and normalizing technologies; and, in this 
emergence, the subject plays a key role, forming a sense of self in 
relation to norms. While discipline focuses at the level of the in-
dividual, what Foucault calls biopolitics operates at the level of the 
population and works to achieve the regulatory control of the mass 
of bodies comprising the population. Foucault argues that this mo-
dality of power—biopolitics—takes “the totality of the concrete pro-
cesses of life in a population . . . [as] the target of security” to make 
the population live (more).14 While the two modes of power can be 
12. Michel Foucault, “Lecture Eleven: 17 March 1976,” in Society Must Be Defended, 
trans. David Macey, ed. Mauro Bertani and Alessandro Fontana (New York: Picador, 
1997), pp. 239–264, quote on p. 253. 
13. Michel Foucault, Discipline and Punish: The Birth of the Prison, trans. Alan Sheridan 
(London: Penguin Books, 1991), p. 170.
14. Thomas Lemke, Biopolitics: An Advanced Introduction (New York: NYU Press, 2011), 
p. 37. Importantly, see Michel Foucault, History of Sexuality, Volume One: The Will to 
Knowledge, trans. Robert Hurley (London: Penguin Books, 1998).
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distinguished by scale, they are, in fact, imbricated: when biopoli-
tics emerges, it draws on and indeed reworks discipline. It does this 
through a series of techniques, technologies, relays, and operations 
that, in Foucault’s intriguing words, “make live.”
 Importantly, Foucault uses the term life—in relation to the con-
cept of making live—to refer to the conditioning of biological ca-
pacities of the individual, and how these capacities are inextricable 
from the logics of governing. Foucault does not propose an ontol-
ogy of life; rather, his concern is how biological life comes to be 
known and conditioned through various mechanisms and tech-
niques—power-knowledge relations—that have taken life as an 
object. Life—living beings and the conduct of the living—becomes 
the arena where biopolitics manages and affirms particular forms 
of life (that is, bodies/selves) that have been produced through dis-
ciplinary mechanisms. Simultaneously, biopolitics comes to shape 
and modify forms of discipline that condition individual bodies. It 
draws on discipline by obliging individuals to enter themselves into 
the discourses of life so that they can then be advised how, through 
discipline, to lead a life, conduct themselves, and self-care. The ends 
of this form of biological governing concern the control, stabilizing, 
and improvement of life. In other words, to “make live” becomes a 
biopolitical imperative. Biopolitics affirms life through the impera-
tive to make live and can thus be said to be a politics of affirmation. 
It orients the biological—living beings—towards life in a regulatory 
fashion. As such, this affirmation cannot be seen as neutral or libera- 
tory. Instead, it is crucial that we recognize that life can only ex-
ist under certain conditions; it is contoured in particular ways; and 
some ways of living, not to mention forms of life, are valued above 
others.
 Biomedicine works in line with these biopolitical goals to make 
live and is called on as an instrument of the governing of life; it 
fosters and regularizes certain forms and understandings of life. 
Therefore, biomedicine must be seen as regulatory, in that it is used 
to fulfill biopolitical imperatives to make live. One of the key ways 
that biomedicine achieves both the biopolitical and disciplinary or-
ganization of life is through affect. Affect is fostered, cultivated, and 
utilized within the biomedical arena, both in the clinical setting and 
in terms of individual engagements with biomedicine and the expe-
rience of illness. If, as Hemmings suggests, “affect manifests . . . as a 
central mechanism of social reproduction” within broader society, 
and, as Constantina Papoulias and Felicity Callard argue, affect is in-
tegral to the regulation of self, then affect can be seen to extend into 
all areas of biomedical rhetoric, practice, and individuals’ encounters 
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with the biomedical sphere.15 This is hauntingly articulated by Mi-
chael Taussig, who notes that “[i]t is within disease, with its terrify-
ing phantoms of despair and hope that my body becomes ripe as 
little else for encoding that which society holds to be real.”16
 While multiple affects permeate medical encounters and condi-
tion individual feelings and responses to medical treatments and ex-
pertise, many critical scholars of biomedicine have identified hope 
as a dominant biomedical affect.17 Showing how hope pervades 
the biomedical arena in a number of ways, critical studies of the 
biomedicine and technoscience fields have analyzed the nuanced 
workings of hope, its deployment and operations at the individual 
and broader social levels: Mary-Jo Del Vecchio Good and colleagues 
have explored what they call the “political economy of hope” in 
oncology culture; Sarah Franklin has examined new reproductive 
technologies as “hope-technologies”; Tiago Moreira and Paolo Palla-
dino have investigated the tensions and mutual parasitism of what 
they call the “regimes of hope and truth”; and Carlos Novas has 
built on the idea of a political economy of hope by applying it to 
the analysis of links among corporations, individuals, and the pro-
duction of biovalue.18 Nik Brown’s sustained attention to hope has 
drawn together multiple scholars working in this area of inquiry, 
and, further, extended understandings of how hope is mediated in 
biomedicine, specifically in terms of biomedical expectations.19 
15. Hemmings, “Invoking Affect” (above, n. 11), p. 551; Papoulias and Callard, 
“Biology’s Gift” (above, n. 9), p. 47.
16. Michael Taussig, “Reification and the Consciousness of the Patient,” Social Science 
and Medicine 14 (1980): 3–13, quote on p. 4. 
17. This is not to say that individuals do not experience other affective states in the 
face of illness (such as shame, anger, fear, or despair among others). These other affects 
are not fostered in the biomedical encounter—or in broader social articulations of 
disease and illness—in the ways that hope is.
18. M. J. Del Vecchio Good, B. J. Good, C. Schaffer, and S. E. Lind, “American Oncology 
and the Discourse of Hope,” Culture, Medicine and Psychiatry 14:1 (1990): 59–79; Sarah 
Franklin, Embodied Progress: A Cultural Account of Assisted Conception (Abingdon, UK: 
Routledge, 1997); Tiago Moreira and Paolo Palladino, “Between Truth and Hope: On 
Parkinson’s Disease, Neurotransplantation and the Production of the ‘Self,’” History of 
the Human Sciences 18:3 (2005): 55–82; Carlos Novas, “The Political Economy of Hope: 
Patients’ Organizations, Science and Biovalue,” BioSocieties 1:3 (2006): 289–305.
19. Nik Brown, “Ordering Hope: Representations of Xenotransplantation—an Actant/
Actor Network Theory Account” (PhD diss., Lancaster University, 1998); “Hope Against 
Hype: Accountability in Biopasts, Presents and Futures,” Science Studies 16:2 (2003): 
3–21; “Shifting Tenses: Reconnecting Regimes of Truth and Hope,” Configurations 13:3 
(2005): 331–355; and “Shifting Tenses—From ‘Regimes of Truth’ to ‘Regimes of Hope,’” 
SATSU Working Paper 30 (2006) (http://www.york.ac.uk/media/satsu/documents 
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 We take the investigation of hope in a different direction by ex-
amining it through the lens of Foucault’s concept of the govern-
ing of life. Here, it is hope’s organizing logic that must be explored, 
and the particular ways that conventions of hope secure the affir-
mation of life. Hope affirms the “truths” that undergird biomedi-
cine.20 These might be understood as the following: techno-utopian 
transcendentalism, or the possibility of transcendence of corporeal 
limits and ends; progress to an undefined future; a salvationary eth-
ics that directs toward optimism; and, more recently, optimization 
and enhancement of the human.21 By affirming these truths central 
to biomedicine, hope fosters life in particular ways. The biomedi-
cal affect of hope orients life toward these truths, and, in doing so, 
conditions conduct and produces biomedical subjects in line with 
the biopolitical imperative to “make live.” Importantly, hope is con-
ventionalized in particular ways that circumscribe what meanings 
or articulations of hope can exist, and how hope is deployed within 
biomedicine. Hope as biomedical affect disciplines individuals to af-
firm (a circumscribed) life—to experience their biomedical subjec-
tivity through conventions of hope, and to hope as the way to ful-
fill the biopolitical imperative to live. Such disciplinary workings of 
hope within biomedicine, in turn, extend outward into the broader 
public arena and organize the masses at the biopolitical register.
 In order to develop these claims further, the remainder of this 
essay focuses on hope in relation to cancer. Today, hope is ubiq-
uitous in public cancer campaigns and services; cancer remains 
one of the clearest, most visible grounds of hope. The operations 
of hope are more observable in some cancers than others—for ex-
ample, breast cancer compared to testicular cancer—but all cancers 
are, to some degree, managed and represented through the biomedi-
cal deployment of hope (and its relays and forays into the public 
-papers/Brown-2006-shifting.pdf). See also Cheryl Mattingly’s work on hope as a 
narrative phenomenology of practice for families with critically ill children in The 
Paradox of Hope: Journeys through a Clinical Borderland (Berkeley: University of California 
Press, 2010).
20. We use the term truth here in the Foucauldian sense, to refer to a regime comprised 
of types of discourse that an individual society “accepts and makes function as true”; 
see Michel Foucault, “Truth and Power,” in Power/Knowledge: Selected Interviews and 
Other Writings, 1972–1977, trans. Colin Gordon, Leo Marshall, John Mepham, and Kate 
Soper, ed. Colin Gordon (New York: Pantheon Books, 1980), pp. 109–133, esp. p. 131.
21. Nikolas Rose, The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the 
Twenty-first Century (Princeton, NJ: Princeton University Press, 2007); Adele E. Clarke, 
Laura Mamo, Jennifer Ruth Fosket, Jennifer R. Fishman, and Janet K. Shim, eds., 
Biomedicalization: Technoscience, Health, and Illness in the U.S. (Durham, NC: Duke 
University Press, 2010).
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realm). Hope is also inextricable from the “hard” technologies of 
biomedicine, such as clinical trials, treatment, experimental bod-
ies, detection technologies, and genetic testing. But while attending 
to hope in relation to hard technologies is important, our purpose, 
here, is to consider the conventions of hope that are at work in the 
social environments of cancer treatment. First, however, it is neces-
sary to address the shifts in the biomedical conventions of hope in 
the neoliberal era, building on the previous theoretical discussion of 
biopolitics, biomedicine, and affect. We turn now to survey cancer 
activism—specifically, breast cancer activism—as the terrain where 
biomedicine, and the biomedical conditioning of hope, can clearly 
be seen to articulate with neoliberal biopolitics. 
Neoliberal Biopolitics and Hope Weaponry
Cancer has long been considered the target of war—that which war 
must be waged against—and hope has historically been fostered 
and deployed as a weapon to fight cancer. However, hope has be-
come militantly optimistic, triumphant, individualistic, and highly 
commercialized in the biomedical and social sphere concentrated 
on cancer over the last several decades. This shift can roughly be 
said to coincide with the transition from the era of medicalization to 
that of biomedicialization: medicalization marked the extension of 
medical jurisdiction across areas of life not previously governed by 
medicine beginning in the early to mid-nineteenth century, while 
biomedicalization can be temporalized to the latter part of the twen-
tieth century and is characterized by, among other things, the in-
tensified reliance upon technology of the biomedical field and the 
extension of medicine from illness into the realm of health.22 The 
logic and conventions of hope that accompany these eras articulate 
varying biopolitical aims, employ distinct disciplinary techniques, 
and consequently produce divergent forms of biocitizenship. This 
term refers to the ways that citizenship, of the nation or of the so-
cial realm, has been increasingly framed and experienced in relation 
to the biological. For Nikolas Rose, biocitizenship marks “all those 
citizenship projects that have linked their conceptions of citizens 
to beliefs about the biological existence of human beings, as indi-
viduals, as men and women, as families and lineages, as communi-
ties, as populations and race, and as species.”23 What we go on to 
show, however, is that biocitizenship does not always take national-
ized form. Indeed, as Rose has argued, in the contemporary era, it 
22. Clarke et al., Biomedicalization (above, n. 21).
23. Rose, The Politics of Life Itself (above, n. 21), p. 132.
394 Configurations
involves medical knowledge of one’s “condition,” a sense of belong-
ing with others who share that condition, and a heightened sense of 
responsibility for one’s own health, enabled through advancements 
in the biomedical sphere and technoscience.
 Hope was first deployed in biocitizenship projects relating to 
cancer in the medicalization era of the late nineteenth and early 
twentieth centuries. During this time, a generalized silence accom-
panied the disease, and there was an overriding popular belief that 
a cancer diagnosis inevitably resulted in death. Despite high inci-
dence and mortality rates, cancer received little public attention. To 
combat these issues and work toward the goal of the promotion of 
life, public education efforts and a series of social-control programs 
were initiated. These projects largely endeavored to “fight cancer 
with publicity” and combat the fear and silence surrounding it with 
hope. The centrality of hope in these biocitizenship projects is most 
clearly seen in the American Society for the Control of Cancer’s (the 
ASCC, which became the American Cancer Society [ACS]) formal 
adoption of the “Sword of Hope” symbol in 1928. The sword was 
used to promote the idea that vigilant detection, knowledge, and 
education would enable individuals to hope that they would not 
succumb to cancer, but could instead battle it and thus make them-
selves live.24 Hope, in this era, was beginning to be militarized; it 
was considered the battle cry to wage war on cancer, and the sword 
rallied hope in order to encourage individuals to take responsibil-
ity for their own health and that of their families, and to discipline 
themselves with the aim of achieving national protection.25 This 
goal required a collective front of biocitizenship, formed through 
the disciplinary techniques of individual awareness, surveillance, 
and acquiescence to medical oversight. The affective work of hope 
within biomedicine at this time operated within the biopolitical 
governing strategies that structured the era of medicalization: ill-
ness was to be controlled, the health of the population was to be 
regularized in line with normative standards, and collective risk was 
24. Barron H. Lerner, The Breast Cancer Wars: Hope Fear, and the Pursuit of a Cure in 
Twentieth-Century America (New York: Oxford University Press, 2003).
25. Integral to this rising public visibility of cancer was the formation of the Women’s 
Field Army (WFA). Established in 1936 and initiated by the ASCC, the WFA adopted 
the Sword of Hope as its moniker and aimed to collectively organize “trench warfare 
with a vengeance against a ruthless killer” (qtd. in ibid., p. 43). This legion of volunteers 
was organized vertically, with an officer’s corps and foot volunteers; enlisted women 
wore khaki uniforms with insignias of rank and achievement. Medals honored length 
of service, and an array of pins and buttons depicting the sword were utilized by the 
WFA and supporters to mark their membership and commitment to the cause. By 
1943, the army numbered between 350,000 and 700,000 (ibid., p. 44).
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to be abated. Thus, the population was administered as a social en-
terprise. Within this logic, cancer was seen as a disease that could 
be controlled by knowing its symptoms and anticipating its signs, 
and thus both hope and cancer’s curability relied upon early detec-
tion once the disease had appeared. This possibility, however, could 
only be mobilized through the militancy of citizens over their own 
bodies and those of their families; to do otherwise meant that one 
failed as a citizen. The Sword of Hope was a call to arms in this en-
terprise, where the conquest of cancer was framed as a civic duty, a 
matter of honor, and a heroic endeavor that required the vigilance 
of the entire population. The welfare and care of the population was 
the focus, beliefs of the “social good” prevailed, and life became a 
responsibility and national duty.26
In contradistinction to this earlier welfare-oriented deployment 
of hope, the latter half of the twentieth century, particularly the 
neoliberal era, has seen a modification and transformation of hope 
logics in biomedicine. Biomedicine operates differently in the era of 
what Melinda Cooper calls “neoliberal biopolitics,”27 which refers 
to a range of social, political, and economic rationalities, programs, 
directives, and policies that work across multiple scales—local, re-
gional, national, global. For our purposes, neoliberal biopolitics can 
be characterized most broadly by a declining welfare imperative and 
the increasing absence of the idea of society or of a collective so-
cial good; a heightened individualizing of the administration and 
management of life; a reworking of life beyond its perceived lim-
its (in contradistinction to the earlier period’s regularizing of life 
and collectivizing of risk). Massive investment in the life sciences 
and biotechnologies from the 1970s onward has effectively led to a 
political economy of life that speculates on life and its possibilities, 
in addition to the administration of life toward a certain telos.28 
26. This militant hope circulated in popular culture, through mediums like posters that 
exhorted citizens to vanquish cancer by learning about it, looking for symptoms, and 
pursuing early diagnosis and treatment. Many of these posters highlight how the ACS 
addressed the personal, specifically the family, as the realm where cancer awareness 
and vigilance needed to be cultivated. Through personal responsibility, cancer could be 
detected and attacked; cancer is framed here as that which could be met with retaliatory 
action. It is the family that serves as the space where a collective front of biocitizenship 
can be imagined; for while various medico-technical advancements were unfolding 
during this time period, national protection and the strength of national health relied 
upon individual and familial participation in these efforts.
27. Melinda Cooper, Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era 
(Seattle: University of Washington Press, 2008), p. 8.
28. Here, the telos would be optimization; see ibid., and Rose, The Politics of Life Itself 
(above, n. 21).
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 Biomedicine operates in line with these shifts. In the contem-
porary period of biomedicalization, biomedicine reflects and con-
ditions the key characteristics of neoliberal-biopolitical existence 
in the United States. Biomedicine increasingly customizes, rather 
than normalizes, the body; it has extended its terrain from illness to 
the more all-encompassing and pervasive regime of “health”; and, 
through the genetic and molecular framing of life, it has provided 
the opportunity to further individualize life and create alternative 
forms of biocitizenry that are focused on militant self-care and pre-
emptive practices, and that move away from an over-arching sense 
of national belonging and protection. Attendant to these shifts in 
biomedicine under neoliberal biopolitics, hope is increasingly cor-
poratized and commodified. There is an intensification of the moral 
obligation to hope; hope is now seen not as a social and collective 
expression of national belonging and welfare, but instead as some-
thing potentially embodied in one’s own biological material and fa-
cilitated by biotech advancements and corporations. Hope remains 
central to governing, but it now involves an intensification of mili-
tarization, a heightened individual triumphalism and insistent opti-
mism, and a relentless effort to optimize life, to make (individuals) 
live (more).
 The Walther P-22 “Hope” edition handgun captures the signifi-
cant neoliberal shifts of hope in biomedicine as they relate to can-
cer and the production of biocitizenry. The figure of a “hope gun” 
paradoxically mobilizes the new optimization of life at the same 
moment that it serves as a technology of killing: the gun’s specter 
of death is absurdly drafted in the service of the cure for cancer. Dis-
count Gun Sales, a US gun-manufacturing company, recently pro-
duced a limited number of these customized pistols, which sported 
a pink Duracoat finish. They were introduced during Breast Cancer 
Awareness Month in 2011 with the original intention of donating 
a portion of the gun-sale proceeds to the Susan G. Komen Founda-
tion for breast cancer research.29 The gun was so successful that, in 
2012, the company initiated a second production line. While we 
do not mean to suggest that the hope gun now serves as the ulti-
mate public image of cancer or the paradigmatic symbol of hope 
under neoliberal biopolitics, its existence does represent the extent 
to which the governing of life has changed. That this gun could 
even be conceived, let alone be commercially successful, indicates 
29. This information was available at the site “Open Letter Concerning the Susan G. 
Komen Foundation,” http://www.discountgunsales.com/SGKF.pdf. All reference to the 
gun has since been removed from the Discount Gun Sales website; however, an 
archived version of the letter is at http://big.assets.huffingtonpost.com/SGKF.pdf. 
Ehlers & Krupar / Hope Logics 397
the massive transformations in the ways that neoliberal governance 
“makes live,” and, specifically, how cancer awareness and activism 
have been militarized.
 Breast cancer activism has witnessed the corporatization and 
commercialization of hope weaponry. Breast cancer currently re-
ceives more coverage than any other, and hope permeates almost 
all rhetoric and practices that surround the disease.30 Breast can-
cer is the disease that inspires, demands, the most hope, and such 
hyper-visible hope has been largely achieved through the commer-
cialization of breast cancer activism and the blurring of education, 
activism, and marketing. For example, the pervasive color known 
as “breast cancer pink” allows for the expression of awareness and 
support for breast cancer activism through pink-branding (“pink-
washing”) and consumerism. Hope is now key to making breast and 
other cancers palatable through the conventions of the commodity. 
A “hope edition” breast-cancer-pink handgun is merely one prod-
uct in a wide array of commodities within cancer popular culture 
and activism wherein hope functions as an affective currency—
hope is bought and sold. By buying the breast cancer handgun (or 
any other kind of hope paraphernalia), one participates in a mar-
ket of/for hope: one buys into a system of optimism and consumer 
identification—an economy sponsored by corporate bodies—to 
show support for the cause. In this context of consumerism, cancer 
continues to be met with war, and breast cancer activism has territo-
rialized that battleground as the disease that demands the most mil-
itarization of hope. However, the incitement to participate in breast 
cancer activism has become so militantly consumeristic and moral-
ized that the purchase of an instrument of killing—an anti–breast 
cancer hope gun—can be justified and even celebrated. While the 
gun is an extreme example, it is not far afield from one of the domi-
nant figures in contemporary US breast cancer culture: the “pink 
warrior,” a highly individualized and triumphalist symbol of resis-
tance to breast cancer. This militant pink hero rallies public hope 
and optimism to combat the threat of cancer in/through commodi-
fied images and ideas of a certain form of feminism—universalized 
sisterhood, self-empowerment, girl power, and so forth—and through 
spectacles of hope, such as mass rallies. 
30. For a comprehensive account of breast cancer activism and politics, see Nadine 
Ehlers and Shiloh Krupar, editors of “The Body in Breast Cancer” special issue in Social 
Semiotics 22:1 (2012); Ehlers, “Risking ‘Safety’: Breast Cancer, Prognosis, and the 
Strategic Enterprise of Life,” The Journal of Medical Humanities (2014). DOI 10.1007/
s10912-014-9288-2 (Online First).; and Barbara Ehrenreich, “Welcome to Cancerland: 
A Mammogram Leads to a Cult of Pink Kitsch,” Harper’s, November 2001, pp. 43–53.
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 This militant hope in breast cancer culture dovetails with a more 
general hyper-vigilant approach to the individual body in the neo-
liberal era of biomedicine. Advancements in biotechnology—the 
“march of progress” to current forms of genetic testing—have initi-
ated new understandings of the body and practices of self-care (forms 
of individual discipline) that emphasize both individual genetic risk 
and health as a continuum. Departing significantly from the earlier 
era’s curative model of disease, the paradigm has now shifted from 
cancer’s curability after evidence of disease to a new form of life—
the search for “the cure”—that involves endless detection and pre-
diagnostic subjection: there is no end to this active search for po-
tential disease, embodied risk, and the cure. Life, then, exists within 
a “pre-vivor” to “survivor” loop, and health has become an endless 
and hyper-vigilant individual enterprise. Breast cancer surveillance, 
in particular, through the historical mounting of biotechnologies, 
from the pap smear in the 1940s, to the mammogram in the 1960s, 
and genetic testing in the 1980s, has become a speculative and end-
less quest for the cure, to the extent that militant medical disciplin-
ing of the body through disease surveillance now traverses all stages 
of life. For example, there have been proposals to remove the breast 
buds of girl children who test positive for the BRCA1/BRCA2 breast 
cancer genes.31 The cure for breast cancer is, therefore, biomedically 
illusive, in that it defers any possibility for the “end” of cancer by 
enfolding persons without symptoms, along with unwanted and 
unknown futures, into the present in the name of hyper-vigilant 
cancer preemption. The hope gun is the penultimate fetish of this 
militant affirmation of life through constant preemptive action. 
 Biocitizenship is thus changing in the era of neoliberal biopoli-
tics: in the absence of collectivizing incentives of welfare notions 
of health, we are now witnessing the emergence of new forms of 
citizenship where individuals increasingly think of themselves in 
relation to their biological, genetic, or corporeal status and disci-
pline themselves accordingly.32 However, if life is now understood as 
that which can be endlessly enhanced, optimized, customized, com-
modified, and biologized, then hope is re-presented and used in our 
31. F. M. Hodges, J. S. Svoboda, and R. S. Van Howe, “Prophylactic Interventions on 
Children: Balancing Human Rights with Public Health,” Journal of Medical Ethics 28:1 
(2002): 10–16, esp. p. 11.
32. In this operation, groups of individuals are claiming “belonging” to a particular 
disease or biological classification, representing what Paul Rabinow has called 
“biosociality”; see Rabinow, “Artificiality and Enlightenment: From Sociobiology to 
Biosociality,” in Incorporations, ed. Jonathan Crary and Sanford Kwinter (New York: 
Zone Books, 1992), pp. 234–252. 
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current era to govern subjects according to these understandings. 
Hope is now articulated (and comes to be embodied) as the refusal 
to be limited to biological capacity; the way to speculate on one’s 
own life, and life in general; the relentless optimism and demand 
for more (individual) life; the hyper-vigilance required of disease 
preemption; and the militant affirmation of the endless productiv-
ity and potential of biotechnology and biomedical advancements. 
Hope logics are structural to biomedical political economies and 
neoliberal biopolitics, and they organize how individuals come to 
incorporate biomedical truths and neoliberal rationalities in their 
daily lives. In incorporating these truths, individuals are not only 
what Foucault would call the inert or consenting targets of biomedi-
cal power/knowledge and governance, but “they are always also the 
elements of its articulation.”33 In the next section, we turn to the 
way that neoliberal conventions of hope are enacted within clinical 
settings related to cancer. In such settings and attendant biomedi-
cal encounters, hope can be seen to govern the subject with cancer. 
We first consider how such governing via hope operates in what we 
call “infrastructures of care”—institutional arrangements and their 
aesthetics of care. Second, we consider how this governing through 
hope operates as a “bioethics of faith,” where both the possibility 
for hope and the ethical relationship of self-to-self and biomedicine-
to-patient are structured as faith.
Care and Faith: Hope in the Biomedical Encounter
It is difficult to imagine any form of cancer care not predicated on 
hope. The sustained marriage between care and hope constitutes the 
very essence of countless cancer-treatment spaces and practices that 
regard fostering hope to be integral to providing care. The pursuit 
of hope as an operation of care is well-established and continues to 
set the stage for biomedical encounters: people interface with bio-
medicine in/through care services that aver hope. In the neoliberal 
era, hope is intensively fostered, and the subject governed, through 
architectures of care that instrumentalize interior design and cus-
tomize medical services in the cause of hope—in other words, the 
increased efficiency and corporatization of care, combined with 
hope thematics. Numerous hospitals, medical centers, and cancer-
treatment hubs employ hope in their titles, such as Hope City in 
Los Angeles, one of only forty National Cancer Institute–designated 
comprehensive cancer-treatment centers. Hope medical-care titles 
33. Michel Foucault, “Two Lectures,” in Power/Knowledge (above, n. 20), pp. 78–108, 
quote on p. 98.
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also have a global presence, demonstrated by the numerous North 
American examples beyond the borders of the United States, such as 
the Breast Cancer Center of Hope in Manitoba, Canada, and the Oa-
sis of Hope Cancer Hospital in Tijuana, Mexico. Many of these treat-
ment centers strive to integrate cancer-care services—blood tests, 
scans, chemotherapy sessions, and other support provisions—under 
one roof. Hope is generated through the efficiencies of a coordi-
nated, consolidated, and comprehensive infrastructure of care. The 
integration of different offices and services reduces patient travel 
and allows for enhanced customization of care. Treatment centers 
organize doctors and medical service professionals into “care teams” 
that collaborate and customize procedures according to each pa-
tient’s needs. The patient is thus treated as an individual fulcrum of 
hope that can be leveraged by a care team, well-organized services, 
and effective architecture.
 Beyond teamwork tailored to each patient and the fostering of 
hope through architectural efficiencies, cancer-care centers also seek 
to cultivate hope through spatial arrangements and decor. Treat-
ment centers increasingly attempt to embody hope—hope as inspi-
rational, calm, compassionate, and optimistic care—in their very 
architectural designs and interiors. For example, the Mission Hope 
Cancer Center in Santa Maria, California, which opened in late April 
2012, offers “comprehensive compassionate cancer care” within one 
three-story, 44,000-square-foot building, featuring a Mediterranean-
style architectural exterior with natural landscaping and vistas of 
the surrounding valley.34 The interior design includes external win-
dows that pool warm, natural light; spacious seating rooms in earth 
tones; large ceiling portals that brighten enclosed rooms with back-
lit images of blue sky; and enlarged nature photographs that serve 
as kiosk screens, room dividers, and window shades and that ex-
press light as natural shading. Surf photography dons many of the 
walls, to exude color and motivational flourishes; expansive win-
dows overlooking the Santa Maria Valley serve as backdrop to the 
administration of chemotherapy on the third floor; and patients un-
dergoing various scans and procedures can gaze on vividly back-lit, 
majestic landscape images that have been incorporated in the ceil-
ings. Such hope-theming, particularly the enlarged nature transpar-
encies, create a calming and contemplative “aquarium-bowl” effect; 
one potentially feels better about one’s disease or illness on viewing 
inspirational nature at every interface within the medical establish-
34. See the Mission Hope Cancer Center website at http://www.missionhope 
cancercenter.com/index.html.
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ment. Mission Hope Cancer Center’s “nature-sanctuary” interior de-
sign conditions patients to admire nature, feel comfortable, be posi-
tive, and pursue treatment of oneself as part of the larger flourishing 
of life. 
 A second example, the University of Arkansas for Medical Sci-
ences (UAMS) Winthrop P. Rockefeller Cancer Institute in Little Rock 
debuted, in 2010, a twelve-story, 300,000-square-foot expansion for 
cancer research, treatment, and outreach. The design of the entire 
building was carefully considered as a means to inspire the hope 
of patients and their families.35 The interior holds numerous hope-
themed environmental attributes: wall-displayed affirmations like 
“While there’s life, there’s hope,” live piano playing, and an atrium 
housing a garden and the “Seed of Hope” sculpture—the hallmark 
of the entire building.36 Carved from white-pearl Turkish marble 
and standing two-feet high, this sculpture of a large seed serves as 
a dedicated monumental receptacle for Seed of Hope tokens.37 Such 
tokens, which feature the logo of the institute on one side and an 
impression of the interior of a seed on the other, are presented to 
patients on the final day of their active cancer treatment. Each pa-
tient is given two seed coins: one token is placed in the sculpture 
to commemorate survivorship, and the other is taken home by the 
patient to keep or to gift to another person as a symbol of hope.38 In 
this scenario, hope is symbolically minted in monetary-coin form 
and pressed into the service of an expansive, contemplative, time-
less, and copyrighted landscape of cancer care, extending from the 
sculpture itself to the larger building surrounding the atrium and 
sculpture and to the pockets and homes of cancer patients and their 
relations. Such an affective economy encourages the cultural accep-
tance of cancer through the visually encouraging accumulation of 
hope; it also primes individuals to accept, internalize, and advertise 
corporatized forms of care. 
 The contemporary corporatization of cancer care—and the con-
tradictions that attend it—can be further explored through examina-
tion of the ACS-administered Hope Lodge® network. Various Hope 
35. “UAMS Expands Cancer Treatment and Research Facilities.” http://www 
.magnoliareporter.com/news_and_business/regional_news/article_d58c680a-9c30 
-11df-8230-001cc4c03286.html?success.
36. See the UAMS Winthrop P. Rockefeller Cancer Institute website at http://www.seeds 
-of-hope.com/.
37. “Artist Creates ‘Hope’ at Cancer Institute,” http://ualr.edu/www/2010/08/03/ualr 
-artist-creates-seeds-of-hope-at-new-cancer-institute/.
38. See http://www.seed-of-hope.com/about-the-seeds-of-hope/. 
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Lodges have been built in urban centers across the United States. 
Each offers cancer patients and their caregivers invaluable free, tem-
porary lodging when specialized cancer treatments are unavailable 
near their homes. Hope Lodges also offer many practical services 
and infrastructures essential to everyday life in order to reduce the 
financial and emotional burdens of cancer treatment: guest rooms 
and private baths, common kitchens, computer work-stations, a li-
brary with educational material on hand, local transportation to and 
from treatment, and additional communal opportunities, including 
yoga, Tai Chi, and shared meals.39 Such care employs the architec-
ture and interior environment to nurture hope, home-like comfort, 
private retreat, and community connection. With thirty-one loca-
tions currently bearing the official trademarked name, Hope Lodges 
serve and simulate community welfare—especially critical in the 
context of the US market-driven healthcare “system,” which pro-
vides few guarantees and limited custody of those facing illness and 
disease. The provision of this hope network presents corporations 
an opportunity to articulate hope through corporate benevolence, 
such as AstraZeneca’s donation of $7 million for the founding of 
the Hope Lodge in Boston in 2006, now accordingly named the “As-
traZeneca Hope Lodge Center.”40 Similar to what critics have called 
“greenwashing,” corporate sponsorship can strategically function as 
“carewashing”—drawing attention to corporate social responsibility 
in one corner, while irresponsible and harmful practices continue 
elsewhere.41 Rather than contributing to the marginalized research 
on the environmental causes of cancer, which could potentially im-
plicate corporations like AstraZeneca and their predecessor compa-
nies, hopeful architectures and networks of care could be seen to 
“band-aid” over what some critics refer to as the “cancer-industrial 
complex”42 or “U.S. Biomedical TechnoService Complex Inc.,”43 ob-
fuscating potential hazards and harms that commence or continue 
39. See the ACS’s Hope Lodge website at http://main.acsevents.org/site/PageServer 
?pagename=ACSHL_homepage.
40. “American Cancer Society Raises $22 Million for Hope Lodge Boston Construction.” 
http://www.cancer.org/myacs/NewEngland/AreaHighlights/american-cancer-society 
-raises-22-million-for-hope-lodge-boston-construction.
41. On “greenwashing,” see Cindi Katz, “Whose Nature, Whose Culture? Private 
Productions of Space and the ‘Preservation’ of Nature,” in Remaking Reality: Nature at 
the Millenium, ed. Bruce Braun and Noel Castree (London: Routledge, 1998), pp. 45–62; 
and Shiloh Krupar, Hot Spotter’s Report: Military Fables of Toxic Waste (Minneapolis: 
University of Minnesota Press, 2013).
42. Ehrenreich, “Welcome to Cancerland” (above, n. 30).
43. Clarke et al., Biomedicalization (above, n. 21).
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under the banner of corporate benevolence and the intensified reli-
ance upon corporate charity as the arena and conduit for medical 
care in neoliberal times.
 Beyond being pursued and fostered in practices of care, hope also 
operates in a second sense in the biomedical arena, as a form of faith. 
US oncology, most specifically, is permeated by a discourse of hope 
as faith in biomedicine, in the self, and in the affirmation of life.44 
Such hope refuses the limits of life and calls on subjects to become 
active participants that instrumentalize the future, discipline them-
selves to be hopeful, and maintain faith in biomedical progress. 
While historically, Western science and medicine can be seen to su-
persede religious truth and salvation with a telos of progress, current 
techno-utopian orientations toward biotechnologies, attendant to 
the shift within biomedicine from control to customization and par-
ticipation, have made hope a bioethics of faith—a never-ending sal-
vationary enterprise wherein subjects internalize the pursuit of hope 
and relentlessly seek to marshal faith in the endless affirmation of 
life through diverse means.
 This bioethics of faith is most clearly seen in oncology, where a 
tension often exists between disclosure—a historically won patients’ 
“right to know”—and the practical need to maintain patient coop-
eration with treatment regimes and what has been called the “prin-
ciple of respect for hope.”45 Although hope has been criticized as 
providing justification for paternalism, the withholding of informa-
tion, and other harms within the biomedical realm, the full disclo-
sure of diagnosis can also be interpreted as medically inappropriate 
if it jeopardizes hope. Prognostic ambiguity and uncertainty, then, 
are the grounds on which disclosing and withholding of informa-
tion are negotiated in the name of securing and managing hope. 
A dedicated interest in fostering hope can subvert the medical im-
perative of full disclosure (at the core of medical ethics), particularly 
when prognoses are bleak, with “facts as the killing fields.”46 When 
truth is not a productive means to manage patients, oncology en-
lists hope as an active therapeutic tool that orients patients to the 
future, affirms life, and rallies faith in the pursuit of always-more 
medical possibilities. Some even consider the oncologist’s vocation 
44. Del Vecchio Good et al., “American Oncology and the Discourse of Hope” (above, 
n. 18).
45. Eric Kadish and Stephen G. Post, “Oncology and Hope,” Journal of Clinical Oncology 
13:7 (1995): 1817–1822, quote on p. 1817.
46. Brown, “Shifting Tenses: Reconnecting Regimes of Truth and Hope” (above, n. 19), 
p. 338; see also Kadish and Post, “Oncology and Hope” (above, n. 45), p. 1818.
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to be that of instilling hope, of balancing the obligation to be hon-
est with “an equally important duty to cultivate hope.”47 Hope is 
understood to be transformative, potent, even capable of influenc-
ing the biological course of cancer; patients, therefore, have a right 
to it. This right to hope is intimately tied to US-based notions of 
effective personhood and faith in the ability of individuals to shape 
life and corporeal functions through the power of will.48 
 This “allegiance to the efficacy of personal volition and the ca-
pacity of the self to mobilize a ‘desire for life,’ a ‘will to live’ and 
a ‘fighting spirit’” is evident in the development and use of “hope 
scales” since the 1970s.49 These instruments of psychometric mea-
surement use affect for intense scrutiny, surveillance, and objecti-
fication; more specifically, they provide a means of assessing how 
much hope you have, through the establishment and deployment 
of norms of acceptable levels of hope. The hope scales involve the 
administration of a carefully crafted series of questions that are then 
scored. Several scales are currently in existence, each exhibiting dif-
ferent nuances and backed by an expansive research network dedi-
cated to the quantitative study of the hopeful properties of cancer 
patients.50 As a whole, these hope diagnostics bifurcate psyche and 
soma, compelling subjects to monitor and regulate the psyche in or-
der to heal the body. They substantiate hope as central to extended 
survival, harmonize patients with the aspirations of treatment pro-
grams, and, by splitting the psyche and soma, foster belief in the 
responsibility of the individual to gather “the necessary affective 
resources in overcoming personalized pathology.”51 Hope is essen-
tially pathologized, and subjects are held accountable for hope’s ab-
sence and disciplined to actively cultivate it.
 Another way that individuals are called on to hope as a form of 
faith is through virtually participating in games that are designed to 
impart knowledge to patient-players about disease and treatments, 
rehearse medical protocols, and cultivate faith in self-efficacy. The 
nonprofit organization HopeLab, which engages in consumer- 
centered product development “to enhance the physical health and 
psychological well-being of young people with chronic diseases,” 
47. Del Vecchio Good et al., “American Oncology and the Discourse of Hope” (above, 
n. 18), p. 75. 
48. Ibid.
49. Brown, “Shifting Tenses–From ‘Regimes of Truth’ to ‘Regimes of Hope’” (above, 
n. 19), p. 12.
50. Ibid., p. 11.
51. Ibid.
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brought together video-game designers, health psychologists, and 
cancer researchers to design a game for young people with can-
cer.52 The intention was to create and market a game that equipped 
patient-players with motivational and transformative affective ex-
periences in order to practice vigilant self-care, virtually battling 
their disease by adhering to the protocols of prescribed medications, 
timely symptom reporting, and side-effect management. The re-
sult was a Microsoft Windows–based, third-person shooter game— 
Re-mission™—released in 2006 with twenty-plus levels of gameplay. 
Re-mission™ invites players to immerse themselves within the com-
plex, microscopic world of cancer-ridden bodies in an epic battle 
against cancer, wherein one’s weapons are upgraded and more life 
is achieved if virtual vigilance is maintained.53 In the game, patient-
players pilot a sassy nanobot named Roxxi through the cellular 
level of teenaged cancer patients to investigate symptoms, destroy 
cancer cells, stop metastases, and activate patients into “chemo 
compliance.”54 Players live out the contingencies of treatment in 
the game’s virtual organic proving grounds. For example, if a pa-
tient skips chemotherapy doses, then Roxxi’s chemo-concentrating 
blaster misfires every third shot and the cancer cells survive and be-
come drug resistant. Considered a flagship for the health-gaming 
movement, with reportedly more than 185,000 copies distributed 
free of charge across eighty-one countries, the game has undergone 
controlled trials to measure its impact on patient behavior, and, 
based on these results, is said to have stimulated an increase in posi-
tive cancer-related attitudes by “transforming mundane medication 
into bullets to kill the enemy cells, and by changing the humdrum 
routine of swallowing pills into a heroic act.”55 Essentially, subjects 
internalize the biomedical pursuit of hope through the game’s re-
hearsal of highly militaristic and individualistic self-care. By playing 
the game, subjects rally faith in biomedicine and, through techno-
utopian transcendence, affirm life, the power of the self, and martial 
52. R. Tate, J. Haritatos, and S. Cole, “HopeLab’s Approach to Re-Mission,” International 
Journal of Learning and Media 1:1 (2009): 29–35, quote on p. 29.
53. The game’s advertising declares that “[a]n epic battle rages deep in the realms of the 
human body. Colonies of microscopic cancer cells are replicating, attacking, and 
damaging healthy organs of young people from all across the United States. Enter 
Roxxi, your courageous and fully-armed nanobot and medicine’s mightiest warrior.” 
See http://www.hopelab.org/innovative-solutions/re-missionTM/.
54. “Re-Mission 2 Video Game Now in Development.” http://www.nanopaprika.eu 
/profiles/blogs/remission-2-video-game-now-in.
55. Kate Metropolis, “Steve Cole,” Health Games Research. http://www.health 
gamesresearch.org/our-publications/featured-colleagues/steve-cole.
406 Configurations
values. Re-mission™ activates a powerful exercise of militarized faith 
in self-efficacy, and in doing so both secures hope and the biopoliti-
cal optimization (of a certain form) of living.
Spiritual guidance around cancer treatment is another area where 
hope as faith proliferates, as a joint venture of medical and religious 
communities. The integration of various spiritual diagnostics and 
services in the formal clinical process of treatment—what is often 
referred to as a holistic approach—increasingly dominates the field 
of cancer care. Regardless of the faith-based religious content at 
work in different cases, the biomedical imperative in oncology to 
foster hope and affirm life interestingly dovetails with many reli-
gious imperatives. For example, research has been underway on the 
hypothesis that individuals with spiritual struggle have greater mor-
tality, and the reverse, that spirituality heals and faith is “medicine’s 
neglected spirit.”56 While biomedicine could be said to use religion 
to generate hope, the reverse could also be asserted. Religious com-
munities have been engaged in biomedicine throughout the history 
of healthcare in the United States. Religiously affiliated hospitals 
and treatment centers, for instance, have a longstanding formal 
presence, especially Christian-oriented care and charity. What is 
new, however, are the explicit promotional claims and niche busi-
nesses of customized/individualized spiritual medical care that are 
taking place within the competitive healthcare market. The Cancer 
Treatment Centers of America (CTCA) emblematizes this significant 
trend, advertising their provision of “mind-body medicine,” spiri-
tual guidance, and a “mother standard of care,” along with cutting-
edge biotechnologies and treatment programs.57 CTCA’s “care that 
never quits” slogan asserts interminable care as the means to endless 
hope, and their highly visible marketing strategy emphasizes the in-
tegration of medical faith and spiritual custodianship—that spiritual 
faith is vital to battling cancer.58 
 A related though less readily apparent facet of the CTCA is its Our 
Journey of Hope® spiritual-support program, which advocates the 
56. See Onoyemi Benedict, “Medicine’s Neglected Spirit: The Positive Therapeutic 
Effect of Spirituality,” on the CTCA’s Our Journey of Hope® website, http://www 
.ourjourneyofhope.com/resources/articles/medicine-s-neglected-spirit-the-positive 
-therapeutic-effect-of-spiritualit.
57. The phrase “mother standard of care” seems to imply the ultimate standard of care 
that, rather than being simply custodial, is representative of love. 
58. See, for instance, Robert L. Dupont, “The Healing Power of Faith: Science Explores 
Medicine’s Last Great Frontier,” on the CTCA’s Our Journey of Hope® website, http://
www.ourjourneyofhope.com/resources/articles.
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communion of faith in care and healing with faith in God.59 This 
salvationary enterprise, which portends to establish relations be-
tween medical and spiritual communities (“when religion and med-
icine embrace”), not only indicates a competitive strategy within 
the neoliberal marketplace of healthcare—the niche of serving spiri-
tual hope and guidance—but also structures individual relations 
with biomedicine in such a way that patients have an opportunity 
to be born again through biomedical encounters, to heal them-
selves through relations with God and renewed Christian faith and 
optimism.60 This extends individual self-care beyond the biologi-
cal limits of the human to vigilance by God. Religion compounds 
the biomedical affirmation of life to proliferate hope: if biomedi-
cal faith is hope in biomedicine to affirm biological life, then its 
combination with faith in God expands hope’s telos beyond life and 
death. This expansion of affirmation beyond life and death, how-
ever, means that individuals now bear intensified moral and social 
responsibility to get healthy through God, matched with biomedi-
cal advancements. An article posted in the resources section of the 
CTCA’s Our Journey of Hope® website, “Don’t Waste Your Cancer,” 
implores readers to see their illnesses as a productive enterprise of 
faith: “You will waste your cancer if you do not believe it is designed 
for you by God. . . . You will waste your cancer if you believe it is 
a curse and not a gift. . . . You will waste your cancer if you seek 
comfort from your odds rather than from God. . . . You will waste 
your cancer if you grieve as those who have no hope.”61 To do oth-
erwise—“to waste your cancer”—is not mere failure, with respect to 
the biopolitical imperative to enhance and optimize life; it is the 
fault of individuals—and individuals are deserving of death—for not 
attending to spiritual care, for not having faith in God, for not al-
lowing cancer to teach them how to be endlessly hopeful. The title 
of another CTCA-posted article alludes to this final judgment and 
the anathema that is death under the evangelical biomedical banner 
of endless hope: “Atheist Doctors More Likely to Hasten Death.”62
59. Ibid.
60. Ibid.
61. The CTCA’s Our Journey of Hope® website, “Don’t Waste Your Cancer,” February 
15, 2006. http://ojoh.hopenavigators.com/resources/articles/don-t-waste-your-cancer.
62. The CTCA’s Our Journey of Hope® website, “Atheist Doctors More Likely to Hasten 




Hoping for Other Things: Alternative Hope Tactics
As evidenced through the operations of care and faith, the affect 
of hope has a governing function in biomedicine. It is deployed in 
ways that support the biopolitical focus on enhancing the life of the 
population and increasingly structures the way that individuals are 
governed. This claim is clearly substantiated through the example 
of cancer culture, wherein hope directs an optimistic orientation to 
the future and to life often predicated on militant organization and 
consumption. Hope is promoted and pursued and comes to func-
tion as a regulatory affect, disciplining social engagements with and 
individual responses to cancer: it affirms life, and this affirming re-
lentlessly circumscribes the kind of life that can be lived and the 
forms of hope that are socially celebrated and endorsed. 
 This affirmation of life through hope is an intervening into life, 
a promoting of life. Biomedicine, here, as Foucault claims, clearly 
operates as “a political intervention-technique with specific power-
effects.”63 However, not all forms of life are fostered equally. In this 
essay, we have not addressed the unequal enhancement of life under 
biopolitics and the overtly violent machinations of neoliberalism. 
There are clear disparities in the possibilities for health and life pro-
duced through the structural and ideological workings of race, class, 
sexuality, gender, and other geopolitical and geographical specifici-
ties. Such inequities in the ability to pursue life or to have one’s life 
affirmed have been theorized in a range of ways—as social death, 
premature death, slow death, or what Foucault referred to as “let 
die.”64 According to him, “letting die” is integral to the biopolitical 
imperative to “make live” and entails various operations of aban-
donment, negligence, and oversight: “In modernity, making live 
and letting die become logical correlates.”65 Due to the vicissitudes 
of resource allocation and social stratification, some are made to live 
(more) at the expense of others.66 The centrality of “letting die” to 
63. Foucault, “Lecture Eleven” (above, n. 12), p. 252. 
64. For more on “social death,” see Orlando Patterson, Slavery and Social Death: A 
Comparative Study (Cambridge, MA: Harvard University Press, 1982); for a discussion of 
“premature death,” see Ruth Wilson Gilmore, Golden Gulag: Prisons, Surplus, Crisis, and 
Opposition in Globalizing California (Berkeley: University of California Press, 2007); and 
for more on “slow death,” see Lauren Berlant, “Slow Death (Sovereignty, Obesity, 
Lateral Agency),” Critical Inquiry 33:4 (2007): 754–780. 
65. Stuart J. Murray, “Thanatopolitics: On the Use of Death for Mobilizing Political 
Life,” Polygraph: An International Journal of Politics and Culture 18 (2006): 191–215, quote 
on p. 197.
66. Stuart J. Murray, “Care of the Self: Biotechnology, Reproduction, and the Good 
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“making live” highlights that death is always inside life; however, 
this death is made invisible.67 
 The biomedical affect of hope plays a specific role in this gen-
eral obfuscating of death in two clear ways. First, in cancer culture, 
hope works to obscure the political character of the disease—for ex-
ample, in the lack of attention directed toward cancer-causing toxic-
ity and pollution and differential access to healthy environments, 
food choices, and the biomedical embrace. In this regard, there are 
“hope haves” and “hope have-nots.” Second, the deployment of 
hope eclipses the realities of the disease by refusing a space to ad-
dress fear, precarity, uncertainty, and pain; for Sarah Lochlann Jain, 
“that politics and suffering is more easily black-boxed behind chip-
per wrapping paper.”68 Moreover, if the biomedical affect of hope 
is constructed as always-already positive and future-oriented, then 
the disease can only be approached as something to be overcome, 
surmounted, or vanquished. This kind of hope is what is called on 
as the acceptable and indeed the only possible response to cancer di-
agnosis and treatment because it is this kind of hope that facilitates 
the triumphant march onwards—to more life. The problem here is 
obviously not hope in and of itself, but the particular conventions 
of hope that are normalized within, and operate as, biopolitical 
governance, and the reality that only certain kinds of life can be 
affirmed and hoped for—positive, ongoing life. The biopolitical af-
firmation of life, conditioned through the conventions of hope that 
we have analyzed, leaves little room to meditate on death or the col-
lateral damage of living under the shadow of imminent death, and 
it renders invisible those individuals who can be said to “live out” 
the let-die component of biopolitics. The vulnerability and often 
“let-die reality” of the subject with cancer does not, cannot, register. 
These are the other lives, ones that fail to achieve “life” as it is known 
in dominant knowledge systems and/or those lives abandoned, 
truncated, or elided in the social sphere. Hope is therefore not inher-
ently “good,” nor is the affirmation of life; rather, hope, as it oper-
ates in the biomedical arena and broader social sphere in relation 
to cancer most specifically, has an ominous quality, with pernicious 
effects. Hope obscures the regulatory and political-economic nature 
of the affirmation of life and circumscribes social responsibility and 
Life,” Philosophy, Ethics, and Humanities in Medicine 2:6 (2007). http://www.peh-med 
.com/content/2/1/6.
67. Ehlers, “Risking Safety” (above, n. 30).
68. Sarah Lochlann Jain, “Survival Odds: Mortality in Corporate Time,” Current 
Anthropology 52:3 (2011): 45–55, quote on p. 46 (emphasis in original).
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ethics; it places the onus on the individual as an agent for life, and 
fosters a militantly optimistic approach to that life. 
 In the context of these conventions of hope, precious few alter-
native articulations or tactics of hope and life in relation to can-
cer exist. Such alternative imaginings are generally overshadowed, 
or risk being deemed pathological, due to their failure to assemble 
and reflect acceptable responses to the disease. Despite this, we 
conclude with several key examples that imagine hope otherwise. 
These “hopeful” alternatives show how hope might be understood 
not as militant affirmation, but as practices that attend to death and 
precarity through recognition of vulnerability. In these alternative 
imaginings, what is hoped for is more tangible, modest, and imme-
diate than triumphant survival. 
The Beautiful and Bald Movement, for instance, began a public 
campaign in 2011 to convince toymaker Mattel to mass-produce a 
bald Barbie doll called Hope, “in support of children living with hair 
loss due to chemotherapy, alopecia, trichotillomania and other auto-
immune diseases.”69 This demand for the Hope Barbie took the form 
of social-networking activism, operating primarily on Facebook, and 
has had overwhelming public support, with more than 150,000 fans 
as of March 2012.70 A prototype of the doll that Mattel did produce 
sported a magnificent diamante-encrusted, black ball-gown, a pink 
stole, and a tiara on her proudly displayed bald head. Such a doll of-
fers an alternative to the contemporary “makeover” imperative that 
compels cancer to be hidden through the maintenance of norma-
tive femininity, which is largely signified through hair, and instead 
actualizes the public display of cancer in its depiction of the harsh 
physical effects of treatments. If released on the mass market, the 
doll could potentially provide young girls with hope for other mod-
els of femininity. While still working within the commercial hope 
culture and representing dominant norms of female embodiment, 
Hope Barbie could simultaneously subvert norms by resignifying 
hair loss, reimagining beauty, and depicting a tantalizing drag or 
glam superhero version of Barbie—with cancer.71 The possibility of 
69. “The Beautiful and Bald Movement: Decorating Domes with Love and Happiness.” 
http://www.beautifulandbald.com. 
70. “Bald Barbie Campaign Convinces Mattel to Produce New Doll.” http://www 
.redorbit.com/news/health/ 1112505299/bald-barbie-campaign-convinces-mattel-to 
-produce-new-doll/.
71. Mattel produced a one-off version of the “Hope Barbie” for 4-year-old cancer 
patient Genesis Reyes in early 2011. The company has recently announced that it will 
now create a bald friend of the Barbie doll for hospital-only circulation. See “Mattel to 
Make ‘Bald Friend of Barbie,’” http://abcnews.go.com/blogs/health/2012/03/29/mattel 
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such a doll, however, was resisted by Andrew Becker, director of me-
dia relations for the ACS, who stated that the Hope Barbie would 
“do more harm than good for kids and parents,” and that children 
“could . . . end up being terrorized by the prospect of it [cancer] in 
a far outsized proportion to their realistic chances [of developing 
the disease].”72 Hope Barbie, for Becker (and by extension the ACS), 
would lead to the evacuation of hope, presumably due to the reali-
ties that the doll would embody. 
 A second example of alternative imaginings of hope is at work 
in the organization called “Hope Cancer Ministries” (HCM).73 This 
nonprofit, faith-based ministry provides practical care and assistance 
for patients, caregivers, and families living with cancer by offering 
services like transportation, meals, home-handymen, housekeeping, 
and financial support for critical needs (for example, utility bills). 
These services attend to the day-to-day needs and the hard realities 
of those affected by cancer and its accompanying treatments when, 
for instance, the need for a ride to chemotherapy or childcare is 
often more immediate than hope for the cure. In the absence of 
a custodial state that might attend to the concerns of those living 
with illness, HCM presents a necessary safety net. It moves away 
from individualistic framings of hope, and instead deploys faith in 
the service of a practical community of health. Simultaneously, such 
practices might be said to offer only a compromised hope because, 
rather than contesting neoliberal forms of depoliticized healthcare, 
they “band-aid” over the shortfalls of the system. Ultimately, how-
ever, hope for help in the daily practice of living with and possibly 
dying of cancer represents a revised vision of hope: as that which 
must be continually reoriented. In this sense, the hope offered 
by HCM dovetails with palliative-care ideology and practice that, 
rather than reproducing the endless “hope through treatment” and 
-to-produce-bald-friend-of-barbie/. On “makeover culture” in relation to cancer, see 
Shelley Cobb and Susan Starr, “Breast Cancer, Breast Surgery, and the Makeover 
Metaphor,” Social Semiotics 22:1 (2012): 83–101; on “glam” as a response to cancer 
makeover culture, see Shiloh Krupar, “The Biopsic Adventures of Mammary Glam: 
Breast Cancer Detection and the Practice of Cancer Glamor,” Social Semiotics 22:1 
(2012): 47–82. 
72. The original blog post, “Bald Barbie is an Over-Reach,” has been removed from the 
ASC website; however, a copy of the Becker post is available at the Jack Morton 
Foundation website, http://thejackmortonfoundation.org/tuesday-january-17-2012/. 
Becker later apologized for his post in “Bald Barbie Demand is an Over-Reach–
UPDATED,” http://acspressroom.wordpress.com/2012/01/13/bald-barbie-demand-is 
-an-over-reach/. 
73. See HCM’s website, http://www.hopecancer.org/.
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“hope in the cure,” faces death by focusing on caring, not curing 
and giving credence to the possibility of dying well. By promoting 
nonhospitalized care at the end of life, palliative care and HCM pro-
vide the dying with hope for more quality time with loved ones, 
pain and symptom management, emotional or spiritual support in 
approaching death, and, ultimately, a good death.
 Finally, Bob Carey’s photographic series titled “The Tutu Proj-
ect” gestures toward more modest and tentative forms of hope in 
relation to cancer culture—wherein, as Jain has stated, “hope and 
exceptionalism pervade . . . like a shrill thread, everyone hanging 
on for dear life and yet still dangling.”74 In this whimsical set of 
images, Carey photographs himself in various locales—cornfields, 
barren hilltops, hanging onto a climbing wall, in the middle of a 
street in the snow—wearing only a scant pink tulle tutu. Inspired 
initially by Carey’s wife’s diagnosis of breast cancer, the project now 
raises awareness and funds for breast cancer research, and might be 
said to stage an implicit critique of dominant breast cancer conven-
tions. A man wearing a pink tutu calls into question the feminiza-
tion of breast cancer culture; a man frolicking, prancing, bounding, 
or standing as a diminutive figure in an unexpected landscape (a de-
serted subway station, a darkened parking lot, a cow paddock) con-
veys a playfulness that highlights the conservatism of cancer poli-
tics; and Carey’s lone and near-naked body stands at odds with the 
mass spectacle of cancer in the broader public sphere. Through de-
picting Carey’s lone figure, his face generally turned from the viewer, 
in often absurd locations and scenarios, these alternative renderings 
also introduce melancholy and vulnerability into the representation 
of cancer and thus push away hope as relentless optimism and the 
conviction to survive. Instead, hope emerges as a subtle, even soli-
tary though not an individualistic, subjunctive possibility and as a 
sharing of humor in times of distress and fear. As Carey has stated, 
“cancer has taught us that life is good, dealing with it can be hard, 
and sometimes the very best thing—no, the only thing—we can do 
to face another day is to laugh at ourselves, and share a laugh with 
others.”75 His articulations do not prioritize the commercialization 
of hope, thus enabling the politics of cancer to be foregrounded. 
They do not represent hope as unencumbered triumphalism, but in-
stead seek space for dealing with messiness, fragility, absurdity, and 
loss and attempt to foster creative and even playful forms of per-
74. Jain, “Survival Odds” (above, n. 68), p. 46.
75. See “About the Tutu Project,” http://www.thetutuproject.com/about/#.UBX 
nDI5rr6E.
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sistence. In one particular image, Carey stoops against a barbed-wire 
fence on what appears to be the deserted edges of a city. Rubbish 
gathered around the fence surrounds him while a Goodyear blimp 
floats in the sky above. Such an image might be said to ironically 
juxtapose the concept of elevation and the vision of the horizon 
(and the hope for a good year?) with limits (the barbed-wire fence), 
abandonment, solitude, and the detritus of daily life. Hope, here, is 
a practice of “artful endurance.”76 
 Taken together, these alternative articulations of hope still affirm 
life, but they do not necessarily frame that life as exclusive of death. 
Moreover, these other ways of hoping perform the difficult and of-
ten painful labor of persisting within the contours of the realities 
of cancer and the fear that can accompany it. Instead of marshal-
ing militant hope, these kinds of hope are fragile; they show forms 
of mourning, maintenance work, and humor. Rather than being 
predicated on future orientation, they focus on grappling with the 
present. Ultimately, these articulations might be said to operate as 
critiques of the dominant conventions of biomedical hope: they in-
tervene into and redirect the ways that hope has come to operate 
and be deployed to govern populations, communities, and senses of 
self in relation to cancer. Here, critique operates as “an instrument 
for those who fight, resist, and who refuse what is. . . . It is a chal-
lenge directed to what is.”77 It signals a refusal to be governed “like 
that and at that cost”78 and an incitement to hope otherwise. 
76. Krupar, Hot Spotter’s Report (above, n. 41).
77. Michel Foucault, “Questions of Method,” in The Foucault Effect: Studies in 
Governmentality, ed. Graham Burchell, Colin Gordon, and Peter Miller (Chicago: 
University of Chicago Press, 1991), pp. 73–86, quote on p. 84. Foucault also states that 
“I would therefore propose, as a very first definition of critique, this general 
characterization: the art of not being governed quite so much” (Michel Foucault, 
“What is Critique?” in The Politics of Truth, trans. Lysa Hochroth, ed. Sylvère Lotringer 
and Hochroth [Los Angeles: Semiotext(e), 1997], pp. 41–81, quote on p. 45). 
78. Foucault, “What is Critique?” (above, n. 77), p. 45. 
